INDICATION

EVENITY™ is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Read More

available osteoporosis therapy. The anabolic effect of EVENITY™ wanes after 12 monthly doses of therapy. Therefore, the duration of EVENITY™ use should be limited to 12 monthly doses. If osteoporosis therapy remains warranted, continued therapy with an antiresorptive agent should be considered. Close

Helping patients manage their bone health after a fracture

Bone Matters™, a patient support program for EVENITY™

For women with osteoporosis after menopause at high risk for fracture, starting a new treatment can raise a lot of questions. You can help them find answers and stay motivated to achieve their bone health goals by introducing them to Bone Matters™, a comprehensive support program.

3 quick ways to enroll

It's easy to help your patients enroll before they leave your office:

icon_fax
FAX:

1-866-790-4994

icon_online
ONLINE:

EVENITY.com/signup

icon_text
TEXT:

Text "ENROLL" to 89183

EVENITY™ PATIENT RESOURCES

EVENITY™ Co-pay Program

Program eligibility requirements, eligibility verification, and co-pay card activation

Bone Matters™: The EVENITY™ Patient Support Program

Exclusive access to lifestyle tips, calcium-rich recipes, educational information, even optional text reminders when it's time to schedule treatment—all to help your patients achieve their bone health goals while on EVENITY™

EVENITY™ patient website

Information about postmenopausal osteoporosis, treatment, and helpful resources for patients who are prescribed EVENITY™

Amgen Assist® is a service that provides tools and resources to support access for your patients

icon_ins_verify

Insurance verification

Verification of patient insurance benefits to determine coverage and OOP costs for EVENITY™

icon_form

Prior authorization (PA) forms

PA forms provided for your office

icon_billing_code

Billing and coding information

Information for office staff about handling billing, coding, and reimbursement for EVENITY™

icon_support

Claims tracking and appeals support

Assistance with claims submission, tracking, and appeals support for appropriate claims

icon_card

Patient support and financial resources

Information on available financial assistance options and help with co-pay card enrollment for eligible patients

icon_resources

Resources about alternate sites of care

Help for you and your patient when the patient needs to receive EVENITY™ at an alternate site of care

For reimbursement support and comprehensive patient assistance, call Amgen Assist® at 1-866-AMG-ASST (1-866-264-2778) Monday through Friday, 9:00 am to 8:00 pm ET, or visit the Amgen Assist® website.

EVENITY™ Field Reimbursement Specialists help your office navigate coverage and claims

EVENITY™ Field Reimbursement Specialists provide personal assistance to your office in 3 primary ways

num1

Provide one-on-one educational support about the claims process

num2

Offer patient-specific support for coverage and reimbursement

num3

Assist your office team with information about billing and coding documentation

PROVIDER RESOURCES

Amgen Assist®

Information on personalized services to support your office and patients throughout the access and reimbursement process

Amgen Assist® Provider Portal

One-stop insurance verification and patient benefit management for registered users

Download ordering and billing information for EVENITY™

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

POTENTIAL RISK OF MYOCARDIAL INFARCTION, STROKE, AND CARDIOVASCULAR DEATH
EVENITY™ may increase the risk of myocardial infarction, stroke and cardiovascular death. EVENITY™ should not be initiated in patients who have had a myocardial infarction or stroke within the preceding year. Consider whether the benefits outweigh the risks in patients with other cardiovascular risk factors. Monitor for signs and symptoms of myocardial infarction and stroke and instruct patients to seek prompt medical attention if symptoms occur. If a patient experiences a myocardial infarction or stroke during therapy, EVENITY™ should be discontinued.

Back to Top